Ascendis Pharma A/S Ordinary Share (ASND) is a publicly traded Healthcare sector company. As of September 9, 2026, ASND trades at $264.00 with a market cap of $17.72B and a P/E ratio of 0.00. ASND moved -3.41% today. Year to date, ASND is +22.31%; over the trailing twelve months it is +28.54%. Its 52-week range spans $118.03 to $282.15. Analyst consensus is strong buy with an average price target of $319.38. Rallies surfaces ASND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ASND news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $264.00 |
| Market Cap | $17.72B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $282.15 |
| 52-Week Low | $118.03 |
| Volume | 420.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
17 analysts cover ASND: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $319.38.